Development, validation and application of a two-site enzyme-linked immunosorbent assay for activin-AB

Journal of Endocrinology

Volumn 153, Issue 2, 1997, Pages 221-230

  Evans, L W ^c   Muttukrishna, S ^a   Knight, P G ^b   Groome, N P ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; MYELOPID;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; OVARY FOLLICLE FLUID; PLACENTA; PREGNANCY; PRIORITY JOURNAL;

EID: 0030989636     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1530221     Document Type: Article

References (55)

1. Atherton E & Sheppard RC 1989 Solid Phase Peptide Synthesis. A Practical Approach. Oxford: IRL Press.
2. Baird DT & Smith KB 1993 Inhibin and related peptides in the regulation of reproduction. Oxford Reviews of Reproductive Biotogy 15 191-232.
3. Baly DL, Allison DE, Krummen LA, Woodruff TK, Soules MR, Chen SA, Fendly BM, Bald LN, Mather JP & Lucas C 1993 Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum. Endocrinology 132 2099-2108.
4. r 32 000 form) on plasma concentrations of FSH and LH in chronically ovariectomized prepubertal heifers. Journal of Endocrinology 125 21-30.
5. Bilezikjian LM, Corrigan AZ & Vale W 1990 Activin-A modulates growth-hormone secretion from cultures of rat anterior-pituitary cells. Endocrinology 126 2369-2376.
6. Brennand JE, Leask R, Kelly RW, Greer IA & Calder AA 1995 Changes in prostaglandin synthesis and metabolism associated with labour, and the influence of dexamethasone, RU 486 and progesterone. European Journal of Endocrinology 133 527-533.
7. Demura R, Suzuki T, Mitsuhashi E, Odagiri E, Eto Y, Sugino H & Demura H 1992 Competitive protein binding assay for activin A/EDF using follistatin: determination of activin levels in human plasma. Biochemical and Biophysical Research Communications 185 1148-1154.
8. Demura R, Suzuki T, Tajima S, Mituhashi E, Demura H & Ling N 1993 Human plasma free activin and inhibin levels during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 76 1080-1082.
9. DePaolo LV, Bicsak TA, Erickson GF, Shimasaki S & Ling N 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proceedings of the Society for Experimental Biology and Medicine 198 500-512.
10. Eramaa M, Hurme M, Stenman UH & Ritvos O 1992 Activin-A erythroid-differentiation factor is induced during human monocyte activation. Journal of Experimental Medicine 176 1449-1452.
11. Goding JW 1986 Monoclonal Antibodies: Principles and Practice. New York: Academic Press.
12. Groome N 1991 Ultrasensitive two-site assays for inhibin-A and activin-A using monoclonal antibodies raised to synthetic peptides. Journal of Immunological Methods 145 65-69.
13. Groome N & Lawrence M 1991 Preparation of monoclonal antibodies to the PA subunit of ovarian inhibin using a synthetic peptide immunogen. Hybridoma 10 309-316.
14. Groome N & O'Brien M 1993 Immunoassays for inhibin and its subunits: further applications of the synthetic peptide approach. Journal of Immunological Methods 165 167-176.
15. Groome NP, Hancock J, Betteridge A, Lawrence M & Craven R 1990 Monoclonal and polyclonal antibodies reactive with the 1-32 amino terminal sequence of the alpha subunit of human ovarian inhibin. Hybridoma 9 31-42.
16. Groome NP, Illingworth PJ, O' Brien M, Cooke I, Ganesan TS, Baird DT & McNeilly AS 1994 Detection of dimeric inhibin throughout the human menstrual cycle by-two-site enzyme immunoassay. Clinical Endocrinology 40 717-723.
17. Groome NP, Illingworth PJ, O'Brien M, Priddle J, Weaver K & McNeilly AS 1995 Quantification of inhibin pro-C-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. Journal of Clinical Endocrinology and Metabolism 80 2926-2932.
18. Groome NP, Illingworth PJ, O' Brien M, Pai R, Rodger FE, Mather JP & McNeilly AS 1996 Measurement of dimeric inhibin-B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 81 1321-1325.
19. Hasegawa Y, Eto Y, Ibuki Y & Sugino H 1994 Activin as autocrine and paracrine factor in the ovary. Hormone Research 41 (Suppl 1) 55-62.
20. Hubner G, Hu QJ, Smola H & Werner S 1996 Strong induction of activin expression after injury suggests an important role of activin in wound repair. Developmental Biology 173 490-498.
21. Knight PG & Muttukrisha S 1994 Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidised (Met O) inhibin. Journal of Endocinology 141 417-425.
22. Knight PG, Groome N & Beard AJ 1991 Development of two-site immunoradiometric assay for dimeric inhibin using antibodies against chemically synthesized fragments of the α and βsubunit. Journal of Endocrinology 129 R9-R12.
23. Knight PG, Muttukrishna S & Groome NP 1996 Development and application of a two-site enzyme immunoassay for the determination of 'total' acrivin-A concentrations in serum and follicular fluid. Journal of Endocrinology 148 267-279.
24. de Kretser DM, Foulds LM, Hancock M & Robertson DM (1994) Partial characterization of inhibin, activin and follistatin in the term human placenta. Journal of Clinical Endocrinology and Metabolism 79 502-507.
25. Krummen LA, Woodruff TK, de Guzman G, Cox ET, Baly DL, Mann E, Garg S, Wong WL, Cossum P & Mather JP 1993 Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids. Endocrinology 132 431-443.
26. LaPolt PS, Soto D, Su JG, Campen CA, Vaughan J, Vale W & Hsueh AJW 1989 Activin stimulation of inhibin secretion and messenger RNA levels in cultured granulosa cells. Molecular Endocrinology 3 1666-1673.
27. Li R, Phillips DM & Mather JP 1995 Activin promotes ovarian follicle development in vitro. Endocrinology 136 849-856.
28. Ling N, Ying SY, Ueno N, Esch F, Denoroy L & Guillemin R 1985 Isolation and partial characterization of an Mr 32 000 protein with inhibin activity from porcine follicular fluid. Proceedings of the National Academy of Sciences of the USA 82 7217-7221.
29. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M & Guillemin R 1986 Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321 779-782.
30. McCullough KC & Spier RE 1990 Selection of monoclonal antibody-secreting hybridoma cell lines. In Monoclonal Antibodies in Biotechnology: Theoretical and Practical Aspects, pp 247-254. Eds J Baddiley, NH Carey, IJ Higgins & WG Potter. Cambridge: Cambridge University Press.
31. McFarlane JR, Foulds LM, Pisciotta A, Robertson DM & de Kretser DM 1996 Measurement of activin in biological fluids by radioimmunoassay, utilizing dissociating agents to remove the interference of follistatin. European Journal of Endocrinology 134 481-489.
32. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H & Seeburg PH 1985 Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318 659-663.
33. Meunier H, Rivier C, Evans RM & Vale W 1988 Gonadal and extragonadal expression of inhibin α, βA, and βB and subunits in various tissues predicts diverse functions. Proceedings of the National Academy of Sciences of the USA 85 247-251.
34. Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR & Knight PG 1994 Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Human Reproduction 9 1634-1642.
35. Robertson DM, Foulds LM, Prisk M & Hedger MP 1992 Inhibin/ activin β-subunit monomer: isolation and characterization. Endocrinology 130 1680-1687.
36. Sadatsuki M, Tsutsumi O, Sakai R, Eto Y, Hayashi N & Taketani Y 1993 Presence and possible function of activin-like substance in human follicular fluid. Human Reproduction 8 1392-1395.
37. Sakai R, Shiozaki M, Tabuchi M & Eto Y 1992 The measurement of activin/EDF in mouse serum: evidence for extragonadal production. Biochemical and Biophysical Research Communications 188 921-926.
38. Sawchenko P, Plotsky P, Pfeiffer S, Cunningham E, Vaughan J, Rivier J & Vale W 1988 Inhibin β in central neural pathways involved in the control of oxytocin secretion. Nature 334 615-617.
39. Schmitt J, Hotten G, Jenkins NA, Gilbert DJ, Copeland NG, Pohl J & Schrewe H 1996 Structure, chromosomal localization and expression analysis of the mouse inhibin/activin beta (C) (INHβC) gene. Genomics 32 358-366.
40. Schneyer AL, O'Neill DA & Crowley WF Jr 1992 Activin-binding proteins in human serum and follicular fluid. Journal of Clinical Endocrinology and Metabolism 74 1320-1324.
41. Schubert D, Kimura H, LaCorbiere M, Vaughan J, Karr D & Fisher WH 1990 Activin is a nerve cell survival molecule. Nature 344 868-870.
42. Shimonaka M, Inouye S, Shimasaki S & Ling N 1991 Follistatin binds to both activin and inhibin through the common beta-subunit. Endocrinology 128 3313-3315.
43. Smith JC, Price BMJ, van Nimmen K & Huylebroeck D 1990 Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin-A. Nature 345 729-731.
44. Thomsen G, Woolf T, Whitman M, Sokol S, Vaughan J, Vale W & Melton DA 1990 Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63 485-493.
45. Totsuka Y, Tabuchi M, Kojima I, Shibai H & Ogata E 1988 Stimulation of inhibin-secretion by transforming growth factor-beta. Biochemical and Biophysical Research Communications 156 335-339.
46. Tuuri T, Erömaa M, Hildén K & Ritvos O 1994 The tissue distribution ot activin βA- and βB-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. Journal of Clinical Endocrinology and Metabolism 78 1521-1524.
47. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D & Spiess J 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321 776-779.
48. Vaughan JM & Vale WW 1993 α2-Macroglobulin is a binding protein of inhibin and activin. Endocrinology 132 2038-2050.
49. Voutilainen R, Eramaa M & Ritvos O 1991 Hormonally regulated inhibin gene expression in human fetal and adult adrenals. Journal of Clinical Endocrinology and Metabolism 73 1026-1030.
50. Wong WL, Garg SJ, Woodruff T, Bald L, Fendly B & Lofgren JA 1993 Monoclonal antibody based ELISAs for measurement of activins in biological fluids. Journal of Immunological Methods 165 1-10.
51. Woodruff TK & Mather JP 1995 Inhibin, activin and the female reproductive axis. Annual Review of Physiology 57 219-244.
52. Woodruff T, Krummen L, Baly D, Garg S, Allison D, Sadick M, Wong W, Mather J Soules M 1993 Quantitative two-site enzyme-linked immunosorbent assays for inhibin A, activin A and activin B. Human Reproduction 8 133-137.
53. Xiao S & Findlay JK 1991 Interactions between activin and FSH suppressing protein and their mechanisms of action on cultured rat granulosa cells. Molecular and Cellular Endocrinology 79 99-107.
54. Yokoyama Y, Nakamura T, Nakamura R, Irahara M, Aono T & Sugino H 1995 Identification of activins and follistatin proteins in human follicular fluid and placenta. Journal of Clinical Endocrinology and Metabolism 80 915-921.
55. Yu J, Shao L, Lemas V, Yu A, Vaughan J, Rivier J & Vale W 1987 Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330 765-767.